Publications
For a full list of publications, click here.
Selected Publications
-
Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy
Patel, S. A., Dalela, D., Fan, A. C., Lloyd, M. R., Zhang, T. Y. Leukemia & lymphoma. 2021.
-
Reprogramming cancer into antigen presenting cells as a novel immunotherapy
Linde, M. H., Gurev, S. F., Phan, P., Zhao, F., Gars, E. J., Stafford, M., Kohnke, T., Marshall, P. L., Fan, A. C., Dove, C. G., Linde, I. L., Miller, L. P., Majzner, R. G., Zhang, T., Majeti, R. AMER ASSOC CANCER RESEARCH. 2021.
-
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia
Zhang TY, Dutta R, Zhao F, Majeti R. Science Translational Medicine. 2020.
-
Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2
Dutta, R., Zhang, T. Y., Köhnke, T., Thomas, D., Linde, M., Gars, E., Stafford, M., Kaur, S., Nakauchi, Y., Yin, R., Azizi, A., Narla, A., Majeti, R. Journal of Clinical Investigation. 2020.
-
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
Azizi A, Ediriwickrema A, Dutta, R, Patel SA, Shomali W, Medeiros B, Iberri D, Gotlib J, Mannis G, Greenberg P, Majeti R, Zhang TY. Leukemia & Lymphoma. May, 2020.
-
Targeting LSCs: Peeling Back the Curtain on the Metabolic Complexities of AML
Zhang, T. Y., Majeti, R. Cell stem cell. 2020.